These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 1091827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Respiratory distress syndrome in the tiny baby.
    Fawcett WA, Gluck L.
    Clin Perinatol; 1977 Sep; 4(2):411-23. PubMed ID: 332436
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The adrenal cortex, steroids, and hyaline membrane disease.
    Reynolds JW.
    Pediatrics; 1971 Apr; 47(4):645-6. PubMed ID: 5108824
    [No Abstract] [Full Text] [Related]

  • 8. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs].
    Puchkov GF, Iazvinskiĭ II.
    Sov Med; 1975 Aug; (8):62. PubMed ID: 1105810
    [No Abstract] [Full Text] [Related]

  • 9. The first expiration: role of pulmonary surfactant.
    Chernick V.
    Semin Perinatol; 1977 Oct; 1(4):351-5. PubMed ID: 382368
    [No Abstract] [Full Text] [Related]

  • 10. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O, Kale G.
    Pathol Res Pract; 2009 Oct; 205(1):35-41. PubMed ID: 18951732
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pulmonary surfactant in neonatal pathology].
    Artus JC, Benezech C, Llory J, Bonnet H, Lesbros D.
    Ann Anesthesiol Fr; 1976 Oct; 17(1):19-28. PubMed ID: 990049
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cellular and biochemical aspects of pulmonary surfactant in health and disease.
    Kikkawa Y, Smith F.
    Lab Invest; 1983 Aug; 49(2):122-39. PubMed ID: 6348405
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F.
    Arch Fr Pediatr; 1985 May; 42(5):397-402. PubMed ID: 3907577
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adrenal gland structure and the development of hyaline membrane disease.
    Naeye RL, Harcke HT, Blanc WA.
    Pediatrics; 1971 Apr; 47(4):650-7. PubMed ID: 5109055
    [No Abstract] [Full Text] [Related]

  • 18. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
    Cotton RB.
    Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.